ANIK
Anika Therapeutics, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$20.22
+1.20%Forward multiples
Based on analyst estimates
- P/E forward
- 21.51x
- P/E 2026E
- 19.30x
- P/E 2027E
- 21.33x
- P/E 2028E
- 17.62x
- P/S forward
- 2.16x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.97x
- Price / sales
- 2.24x
- Price / cash flow
- 45.27x
Enterprise value
- Enterprise value
- $255.5M
- EV / sales
- 2.12x
- EV / EBITDA
- 93.94x
- EV / EBIT
- -49.89x
- Market cap
- $270.6M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026